Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2

September 26, 2022

https://www.globenewswire.com/news-release/2022/09/26/2522474/0/en/Enzo-Biochem-Inc-Launches-AMPIVIEW-Gene-Expression-Platform-with-First-Products-Targeting-Detection-of-HPV-and-SARS-CoV-2.html

NEW YORK, NY, Sept. 26, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEW™ line, a breakthrough RNA gene expression platform powered by Enzo’s LoopRNA™ in situ hybridization technology. The AMPIVIEW™ platform with its first products for HPV detection and analysis significantly expands Enzo’s position in the oncology market and paves the way for expansion into the growing spatial biology space.

Read more at globenewswire.com

Related news for (ENZ)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.